DYANAVEL XR, Quillivant XR, and QuilliChew ER have a significant opportunity for abuse and misuse and will cause material use challenges, such as habit. Continue to keep these medicines in a safe position to prevent abuse and misuse. Marketing or giving away these medicines could hurt Other folks which is against the regulation.The limited answer i